Total Payments
$5,328
2024 Payments
$1,678
Companies
26
Transactions
278
Medicare Patients
1,357
Medicare Billing
$210,100
Payment Breakdown by Category
Food & Beverage$5,120 (96.1%)
Education$208.10 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,120 | 274 | 96.1% |
| Education | $208.10 | 4 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $722.58 | 38 | $0 (2024) |
| ABBVIE INC. | $718.45 | 32 | $0 (2024) |
| Corium, LLC | $571.12 | 24 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $535.13 | 35 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $490.84 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $454.14 | 26 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $279.72 | 12 | $0 (2024) |
| Almatica Pharma LLC | $233.98 | 12 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $175.22 | 9 | $0 (2023) |
| ITI, Inc. | $171.34 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,678 | 74 | Corium, LLC ($341.45) |
| 2023 | $1,288 | 67 | Otsuka America Pharmaceutical, Inc. ($299.31) |
| 2022 | $847.01 | 48 | ABBVIE INC. ($140.74) |
| 2021 | $442.18 | 25 | Takeda Pharmaceuticals U.S.A., Inc. ($128.57) |
| 2020 | $315.73 | 20 | Teva Pharmaceuticals USA, Inc. ($58.13) |
| 2019 | $585.29 | 33 | Janssen Pharmaceuticals, Inc ($136.32) |
| 2018 | $109.74 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($35.52) |
| 2017 | $61.44 | 3 | Shire North American Group Inc ($39.10) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $34.19 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: ADHD | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Central Nervous System | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $0.49 | General |
| Category: Central Nervous System | ||||||
| 08/21/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 342 | 855 | $92,945 | $52,510 |
| 2022 | 3 | 276 | 644 | $77,793 | $41,023 |
| 2021 | 3 | 290 | 628 | $77,100 | $49,465 |
| 2020 | 8 | 449 | 1,059 | $126,590 | $67,102 |
Total Patients
1,357
Total Services
3,186
Medicare Billing
$210,100
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 414 | $61,364 | $34,623 | 56.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 104 | 297 | $25,245 | $14,406 | 57.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 24 | 33 | $3,630 | $2,129 | 58.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 76 | 111 | $2,706 | $1,352 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 358 | $52,908 | $27,289 | 51.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 113 | 263 | $22,355 | $12,260 | 54.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 18 | 23 | $2,530 | $1,474 | 58.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 158 | 367 | $54,390 | $35,182 | 64.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 115 | 240 | $20,400 | $12,954 | 63.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 17 | 21 | $2,310 | $1,329 | 57.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 159 | 460 | $68,655 | $34,368 | 50.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 140 | 391 | $33,235 | $20,026 | 60.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 61 | $6,675 | $3,321 | 49.8% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 43 | 50 | $5,500 | $3,276 | 59.6% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 35 | 35 | $6,125 | $3,163 | 51.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $3,500 | $1,844 | 52.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 15 | $1,500 | $852.75 | 56.9% |
| 90785 | Interactive complexity | Office | 2020 | 16 | 28 | $1,400 | $250.68 | 17.9% |
About Jun Liu
Jun Liu is a Psychiatry healthcare provider based in Madison, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1184019903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jun Liu has received a total of $5,328 in payments from pharmaceutical and medical device companies, with $1,678 received in 2024. These payments were reported across 278 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,120).
As a Medicare-enrolled provider, Liu has provided services to 1,357 Medicare beneficiaries, totaling 3,186 services with total Medicare billing of $210,100. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Madison, AL
- Active Since 03/30/2015
- Last Updated 07/07/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1184019903
Products in Payments
- VRAYLAR (Drug) $833.65
- Azstarys (Drug) $465.52
- TRINTELLIX (Drug) $442.41
- REXULTI (Drug) $362.76
- SPRAVATO (Drug) $353.53
- CAPLYTA (Drug) $216.61
- AUSTEDO (Drug) $205.76
- ABILIFY ASIMTUFII (Drug) $188.75
- QELBREE (Drug) $182.05
- ABILIFY MAINTENA (Drug) $162.29
- Auvelity (Drug) $148.53
- LOREEV XR (Drug) $132.16
- HETLIOZ (Drug) $117.24
- AZSTARYS (Drug) $105.60
- Qelbree (Drug) $97.67
- Austedo XR (Drug) $87.76
- UZEDY (Drug) $85.83
- INVEGA SUSTENNA (Drug) $85.63
- XYREM (Drug) $83.01
- Trintellix (Drug) $77.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Madison
David Plante, Md, MD
Psychiatry — Payments: $118,445
Psychiatry $118,445
Dr. Sobia Kirmani Moe, M.d, M.D
Psychiatry — Payments: $60,165
Psychiatry $60,165
Kenneth Herrmann, Md, MD
Psychiatry — Payments: $60,047
Psychiatry $60,047
Ned Kalin, Md, MD
Psychiatry — Payments: $47,050
Psychiatry $47,050
Charles Raison, M.d, M.D
Psychiatry — Payments: $36,164
Psychiatry $36,164
Anika Wilson, Md, MD
Psychiatry — Payments: $34,601
Psychiatry $34,601